Anti-Müllerian Hormone as a Diagnostic Tool for Polycystic Ovary Syndrome Under Different Diagnostic Criteria Among Unselected Population

ConclusionAMH has poor to fair validity to diagnose PCOS among an unselected group of women, except for patients bearing all features of the syndrome (Phenotype A). This finding is valid using the NIH, Rotterdam and AE-PCOS Society criteria and even after revising the definition of PCOM as AFC≥20.
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research